Previous Close | 102.36 |
Open | 102.35 |
Bid | 98.91 x 800 |
Ask | 101.17 x 900 |
Day's Range | 98.50 - 102.60 |
52 Week Range | 65.28 - 116.97 |
Volume | |
Avg. Volume | 697,454 |
Market Cap | 9.012B |
Beta (5Y Monthly) | 0.94 |
PE Ratio (TTM) | 20.02 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Supply Agreement to Pilot Ultrafiltration Therapy Services Offering in Select MarketsMINNEAPOLIS, June 20, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced it has entered into a Supply and Collaboration Agreement with DaVita Inc. (NYSE: DVA) to pilot Aquadex ultrafiltration therapy to treat adult patients with congestive heart failure and related conditions within select U.S. mark
Medtronic plc (NYSE: MDT) and DaVita Inc. (NYSE: DVA) today announced the launch of Mozarc Medical—an independent new company committed to reshaping kidney health and driving patient-centered technology solutions.